Stock listing

NASDAQ:TCDA Tricida Inc Stock

Follow Tricida Inc into a list and get an email when it puts out news.

Delisted NASDAQ:TCDA no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:TCDA
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Tricida Inc on 6ix

Calls
7 calls with a replay · 7 with a transcript · latest Aug 8, 2022
Decks
9 decks · latest Nov 17, 2022

Where Tricida Inc is listed

ListingExchangeCountryCurrency
NASDAQ:TCDA · This page · DelistedNASDAQUnited StatesUSD
OTC:TCDAQ · DelistedOTCUnited StatesUSD

Events

CallWhenStatus
Tricida (TCDA) Q2 2022 Earnings CallMon, Aug 08, 2022 · 4:30 PM ETReplay
Tricida (TCDA) Q1 2022 Earnings CallTue, May 10, 2022 · 4:30 PM ETReplay
Tricida (TCDA) Q4 2021 Earnings CallTue, Mar 29, 2022 · 4:30 PM ETReplay
Tricida (TCDA) Q3 2021 Earnings CallMon, Nov 08, 2021 · 4:30 PM ETReplay
Tricida (TCDA) Q2 2021 Earnings CallMon, Aug 09, 2021 · 4:30 PM ETReplay
Tricida (TCDA) Q1 2021 Earnings CallThu, May 06, 2021 · 4:30 PM ETReplay
Tricida (TCDA) Q4 2020 Earnings CallThu, Feb 25, 2021 · 4:30 PM ETReplay

Open Events

Decks

DeckKindSlidesDate
Corporate Update (November 2022)Corporate update42 slidesNov 17, 2022
Investor Presentation (January 2022)Investor deck33 slidesJan 10, 2022
Investor Presentation (March 2021)Investor deck35 slidesMar 2, 2021
Investor Presentation (January 2021)Investor deck35 slidesJan 11, 2021
Corporate Update (December 2020)Corporate update16 slidesDec 8, 2020
Corporate Update (October 2020)Corporate update19 slidesOct 29, 2020
Investor Presentation (April 2020)Investor deck47 slidesApr 15, 2020
Investor Presentation (January 2020)Investor deck37 slidesJan 13, 2020
Investor Presentation (January 2019)Investor deck33 slidesJan 7, 2019

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Kathryn Falberg
Other companies: Nuvation Bio Inc. (Board of Directors · Since at least Feb 10, 2021); Arcus Biosciences, Inc. (Board Member · Since at least Mar 14, 2018); The Trade Desk, Inc. (Director · Since at least Sep 20, 2016); UroGen Pharma Ltd. (Director · Jan 1, 2019 – Jun 7, 2021 · Past); Sio Gene Therapies Inc (Director · Apr 7, 2017 – May 15, 2017 · Past); BioMarin Pharmaceutical Inc. (Director · Jul 15, 2016 – Jul 15, 2016 · Past); Aimmune Therapeutics Inc (Director · Aug 5, 2015 – Oct 10, 2020 · Past); aTyr Pharma, Inc. (Director · May 6, 2015 – May 24, 2016 · Past); Medivation Inc (Director · Jan 31, 2013 – Sep 28, 2016 · Past); Jazz Pharmaceuticals plc (EVP and CFO · Dec 1, 2009 – Mar 5, 2014 · Past); Novelion Therapeutics Inc (Director · Mar 25, 2009 – May 26, 2011 · Past); Oruka Therapeutics, Inc. (CFO and COO · Feb 23, 2009 – Jun 25, 2009 · Past); Halozyme Therapeutics, Inc. (Director · May 15, 2007 – May 4, 2016 · Past)
Director · Jun 27, 2018 – Jun 15, 2022 · Past
David Hirsch
Other companies: Rapid Micro Biosystems, Inc. (Director · Jul 14, 2021 – May 23, 2024 · Past); Poseida Therapeutics Inc (Director · Jul 9, 2020 – Jul 23, 2021 · Past); Molecular Templates Inc (Director · Aug 1, 2017 – Jun 3, 2022 · Past); Collegium Pharmaceutical, Inc. (Director · May 6, 2015 – May 20, 2020 · Past)
Director · Jun 27, 2018 – Jun 15, 2022 · Past
Robert J Alpern
Other companies: AbbVie Inc. (Director · Since at least Dec 12, 2012); Abbott Laboratories (Director · Since at least Oct 10, 2008)
Director · Jun 27, 2018 – Nov 23, 2022 · Past
Edward J Hejlek
Other companies: Enovix Corporation (See Remarks · Jul 14, 2021 – Nov 6, 2022 · Past)
EVP, General Counsel & Secy. · Jun 27, 2018 – Mar 2, 2020 · Past
Jeroen B Van Beek
Other companies: Kalaris Therapeutics, Inc. (Chief Commercial Officer · Jul 29, 2020 – Nov 16, 2022 · Past)
Chief Comm Officer and Sr VP · Jun 27, 2018 – Jul 2, 2018 · Past
Klaus R Dr Veitinger
Other companies: Scpharmaceuticals Inc (Director · Since at least Jun 14, 2022)
Director · Jun 15, 2022 – Jun 15, 2022 · Past
Marc Cobo
Other companies: BridgeBio Oncology Therapeutics, Inc. (Vice President of Finance and Controller · Since at least Apr 21, 2026)
SVP, Finance & CAO · Jun 29, 2020 – Sep 10, 2020 · Past
Dawn Parsell OttoEVP, Clinical Development · Aug 1, 2018 – Feb 28, 2022 · Past
Gerrit KlaernerPresident and CEO, Director · Jun 27, 2018 – Feb 28, 2022 · Past
Jerry M BuysseChief Scientific Offr & Sr VP · Jun 27, 2018 – Jun 27, 2018 · Past
All 13 people
PersonSeat
Robert McKagueEVP, General Counsel · Mar 9, 2020 – Feb 28, 2022 · Past
Sandra I CoufalDirector · Jun 27, 2018 – Jun 15, 2022 · Past
Susannah CantrellEVP, Chief Comm. Officer · Jan 28, 2019 – Sep 10, 2020 · Past

Open People

Log in to ask 6ix AI your own questions about Tricida Inc.